We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

551 hedge funds and large institutions have $19.4B invested in St Jude Medical in 2016 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 177 increasing their positions, 226 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 4343 (0)

2% less capital invested

Capital invested by funds: $19.8B → $19.4B (-$402M)

3% less funds holding

Funds holding: 570551 (-19)

14% less first-time investments, than exits

New positions opened: 56 | Existing positions closed: 65

22% less repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 226

40% less call options, than puts

Call options by funds: $43.9M | Put options by funds: $73M

Holders
551
Holders Change
-19
Holders Change %
-3.33%
% of All Funds
13.78%
Holding in Top 10
43
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
1.07%
New
56
Increased
177
Reduced
226
Closed
65
Calls
$43.9M
Puts
$73M
Net Calls
-$29.1M
Net Calls Change
+$231M
Name Holding Trade Value Shares
Change
Change in
Stake
ACPU
26
Arrowgrass Capital Partners (US)
Delaware
$189M +$7.83M +98,618 +4%
BG
27
BlackRock Group
United Kingdom
$176M -$29.2M -367,576 -14%
TS
28
Twin Securities
New York
$174M +$114M +1,438,149 +195%
UOC
29
UBS O'Connor
Illinois
$173M +$53.5M +674,652 +45%
Norges Bank
30
Norges Bank
Norway
$166M -$4.19M -52,778 -2%
AA
31
AQR Arbitrage
Connecticut
$162M -$5.16M -65,070 -3%
Boston Partners
32
Boston Partners
Massachusetts
$162M -$197M -2,482,862 -55%
HSBC Holdings
33
HSBC Holdings
United Kingdom
$161M +$51.6M +650,182 +48%
JP Morgan Chase
34
JP Morgan Chase
New York
$159M +$40.8M +514,145 +35%
WIC
35
Water Island Capital
New York
$150M +$56.9M +716,859 +62%
WCMNY
36
Westchester Capital Management (New York)
New York
$146M -$227K -2,859 -0.2%
Two Sigma Investments
37
Two Sigma Investments
New York
$142M +$7.52M +94,715 +6%
AAM
38
Alpine Associates Management
Florida
$138M -$30.7M -386,200 -18%
Wells Fargo
39
Wells Fargo
California
$125M +$52.8M +665,064 +74%
TCA
40
Taconic Capital Advisors
New York
$120M +$15.9M +200,000 +15%
Millennium Management
41
Millennium Management
New York
$109M -$13.3M -167,102 -11%
UBS Group
42
UBS Group
Switzerland
$108M -$29.1M -366,060 -21%
Legal & General Group
43
Legal & General Group
United Kingdom
$105M +$1.35M +16,946 +1%
Renaissance Technologies
44
Renaissance Technologies
New York
$105M +$104M +1,310,913 New
CI
45
Cowen Inc
New York
$99.8M -$86.3M -1,087,711 -47%
GLAM
46
Gardner Lewis Asset Management
Pennsylvania
$99.6M +$24.9M +313,859 +34%
CS
47
Credit Suisse
Switzerland
$91.3M -$10.2M -128,460 -10%
Caisse de Depot et Placement du Quebec (CDPQ)
48
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$86.9M -$1.29M -16,200 -1%
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$85.9M -$3.28M -41,356 -4%
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
$80.2M -$15.8M -198,915 -17%

STJ Hedge Fund Activity: Q4 2016 in Review

551 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2016, worth a combined $19.4B — down 2% from $19.8B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of STJ and 56 opened new positions — a net loss of 9 holders — while 226 trimmed existing stakes and 177 added.

The largest buyer was HBK Investments, adding an estimated $257M. The largest seller was Third Point, exiting entirely with an estimated $207M sold.

  • 551 institutional investors held St Jude Medical (STJ) as of Q4 2016, down from 570 in Q3 2016.
  • Funds reported $19.4B of St Jude Medical stock for Q4 2016, down 2% quarter-over-quarter.
  • 56 funds opened new St Jude Medical positions in Q4 2016 and 65 closed out, a net change of -9 holders.
  • The largest St Jude Medical buyer in Q4 2016 was HBK Investments, an estimated $257M added.
  • The largest St Jude Medical seller in Q4 2016 was Third Point, an estimated $207M sold.

Based on aggregated 13F filings for Q4 2016.